An all-new version of mmm-online.com just launched
It’s faster, friendlier, and more flexible. Read all about the online enhancements here.
Most recent articles by Marc Iskowitz
Transparency may have taken a back seat on this diversity drive
MM&M/Publicis Health’s first Diversity Survey reveals some notable shifts to making the healthcare industry more inclusive, yet many agencies didn’t feel like opening up about their diversity numbers.
How drugmakers are facing the entrance of consumer giants into healthcare
As deepening healthcare forays by tech and e-commerce giants ratchet up the pressure on pharma to become more consumer friendly, drugmakers are still defining their new role.
Agencies enable staff to find well-being through work
Anatomy of Agency Culture is a supplement designed not only to showcase internal programs, but to examine them with an eye on how they impact company culture.
Data-driven. Obsessive. A little pushy. Meet this year’s Top 40 Healthcare Transformers
Those on the vanguard of transformation include a number of upstarts and veteran gurus taking on historic challenges plaguing health data.
Shortening the drug side-effect list, and five other ways pharma DTC is set to be reformed
MM&M hosted an event in Boston devoted to discussing topics and trends for the DTC marketer.
Sandoz signs on to lead launch of Pear’s digital therapeutics
A deal with Sandoz to lead the global launch of Pear’s two lead products puts marketing muscle behind the nascent class of ‘prescription digital therapeutics.’
Will the real patient advocate please stand up?
Industry opponents say the end is nigh for pharma’s ability to deduct expenses for consumer drug advertising, but those who’ve found their calling in healthcare comms ought to have something to say about that.
From the Editor: Game Changers 2018
Ask someone who works in healthcare marketing, clinical research, or manufacturing to name the defining characteristics of their job. They’re likely to cite ethics right up there with improving human health. Either voluntarily or as a consequence of prior transgressions, industry has had to create ethics codes, such as informed consent for human trials,…
Purdue’s Point of No Return
Purdue’s decision to pull OxyContin sales reps highlights what has been the biggest part of marketing budgets. Did we just see the tipping point?
